Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10
Clinical trial NCT02329730 · COMPLETED
Trial details
- NCT number
- NCT02329730
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-06-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.